Actively Recruiting
Comparing Phacoemulsification with Goniotomy Versus Medication for Medically-Controlled Primary Open-Angle Glaucoma With Cataract
Led by Sun Yat-sen University · Updated on 2024-12-11
100
Participants Needed
1
Research Sites
169 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of two surgical approaches for patients with medically-controlled primary open-angle glaucoma POAG who also have cataracts. This multicenter non-inferiority randomized controlled trial compares phacoemulsification with intraocular lens implantation PEI combined with goniotomy GT against PEI combined with medication therapy MED. The study aims to determine if PEIGT is not worse than PEIMED in lowering intraocular pressure and to assess the economic value of PEIGT in reducing medication use and improving quality of life. Participants will be randomly assigned to either the experimental group receiving PEIGT or the control group receiving PEIMED. The PEIGT procedure involves a standard cataract surgery followed by a minimally invasive goniotomy using a microhook to incise the trabecular meshwork and Schlemms canal over 120 degrees. The PEIMED group undergoes the same cataract surgery, followed by medication based on intraocular pressure measurements targeting 16 mmHg, following established glaucoma guidelines. The follow-up period for primary outcomes is one year. During the study, participants will be monitored at multiple postoperative intervals to measure intraocular pressure, surgery success, and medication usage. Cost-effectiveness parameters will also be evaluated after 12 months. Visual acuity and glaucoma control will be assessed through clinical exams and perimetry. Participants must consent to follow-up visits and assessments throughout the study duration, which extends to the end of 2029.
CONDITIONS
Brief Title
Evaluation of Phacogoniotomy in Medically-controlled POAG
Research Team
X
Xiulan Zhang, MD. PhD
Y
Yunhe Song, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here